Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Antibody–Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity
2019
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry
2012
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
2015 StandoutNobel
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists
2005
Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)
2013
Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
2018
Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy
2011
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
Management of gram-positive bacterial infections in patients with cancer
2011
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
2003
Natural products: An evolving role in future drug discovery
2011 Standout
Kikuchi–Fujimoto Disease: analysis of 244 cases
2006 Standout
Diagnosis ofToxoplasma gondiiinfection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny
2010
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses
2005
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study
2012
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Candida albicanspathogenicity mechanisms
2013 Standout
Update on antifungal treatment of invasive Candida and Aspergillus infections
2004
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Bench-to-bedside review: Candida infections in the intensive care unit
2008
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Graft-versus-host disease
2009 Standout
Antifungal Agents for Secondary Prophylaxis Based on Response to Initial Antifungal Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Prior Pulmonary Aspergillosis
2014
Emerging echinocandins for treatment of invasive fungal infections
2006
Candida as a risk factor for mortality in peritonitis*
2006
Best practice in treating infants and children with proven, probable or suspected invasive fungal infections
2011
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
2016
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Epidemiology and Clinical Manifestations of Mucormycosis
2012
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012
Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study
2015
Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease
2011
Zygomycosis (mucormycosis): emerging clinical importance and new treatments
2004
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
2016 Standout
Echinocandins for Candidemia in Adults without Neutropenia
2006
Caspofungin
2005
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients
2019
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
2006
Otomycosis: Diagnosis and treatment
2010
Co-infections in people with COVID-19: a systematic review and meta-analysis
2020 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
2010
Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation
2019
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea
2013
Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes
2012 Standout
Scope and Impact of Financial Conflicts of Interest in Biomedical Research
2003 Standout
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology
2009
Problems in the Design and Reporting of Trials of Antifungal Agents Encountered During Meta-analysis
1999
Industry sponsorship and research outcome
2012 Standout
Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis: Results of a Prospective Observational Registry
2010
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
2010
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
The clinical spectrum of pulmonary aspergillosis
2014
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients
2014
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Population Pharmacokinetics of Fluconazole in Young Infants
2008
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Investigational CD33-targeted therapeutics for acute myeloid leukemia
2018
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
2006
Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection
2015
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre: Rational approach towards the patient with cancer, fever and neutropenia
2005
Aspergillosis of bones and joints – a review from 2002 until today
2014
Interventions for treating oral mucositis for patients with cancer receiving treatment
2010
Double Induction Containing Either Two Courses or One Course of High-Dose Cytarabine Plus Mitoxantrone and Postremission Therapy by Either Autologous Stem-Cell Transplantation or by Prolonged Maintenance for Acute Myeloid Leukemia
2006
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive Aspergillosis
2013
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality
2013
Burn Wound Infections
2006 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis
2007
Guidelines for Treatment of Candidiasis
2004 Standout
Treatment options of invasive fungal infections in adults
2006
Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real‐life combo study
2013
Hidden Killers: Human Fungal Infections
2012 Standout
Aerosolized Amphotericin B Lipid Complex as Adjunctive Treatment for Fungal Lung Infection in Patients with Cancer‐Related Immunosuppression and Recipients of Hematopoietic Stem Cell Transplantation
2013
Industry sponsorship and research outcome
2017 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Gerda Silling being referenced
Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
2008
Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors
2003
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial
2014
Community acquired respiratory virus infections in cancer patients—Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology
2016
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients
2005
Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*
2007
Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology
2005
Randomized phase III study of granulocyte transfusions in neutropenic patients
2008
Treatment of fungal infections in hematology and oncology
2003
Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry
2009
Forty-one recent cases of invasive zygomycosis from a global clinical registry
2009
A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II
2006
Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
2013
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
2005
Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
2015
High-dose chemotherapy followed by allogeneic stem cell transplantation in high-risk relapsed and refractory aggressive non-Hodgkin lymphoma: Results of a prospective study of the German high-grade non-Hodgkin lymphoma study group.
2012
Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
2011
Treatment of Severe Candida Infections in High-Risk Patients in Germany: Consensus Formed by a Panel of Interdisciplinary Investigators
2002
Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients
2011
Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine
1999
Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography
2007
Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets
2004